Hasumi, K.; Aoki, Y.; Watanabe, R.; Hankey, K.G.; Mann, D.L.
Therapeutic Response in Patients with Advanced Malignancies Treated with Combined Dendritic Cell–Activated T Cell Based Immunotherapy and Intensity–Modulated Radiotherapy. Cancers 2011, 3, 2223-2242.
https://doi.org/10.3390/cancers3022223
AMA Style
Hasumi K, Aoki Y, Watanabe R, Hankey KG, Mann DL.
Therapeutic Response in Patients with Advanced Malignancies Treated with Combined Dendritic Cell–Activated T Cell Based Immunotherapy and Intensity–Modulated Radiotherapy. Cancers. 2011; 3(2):2223-2242.
https://doi.org/10.3390/cancers3022223
Chicago/Turabian Style
Hasumi, Kenichiro, Yukimasa Aoki, Ryuko Watanabe, Kim G. Hankey, and Dean L. Mann.
2011. "Therapeutic Response in Patients with Advanced Malignancies Treated with Combined Dendritic Cell–Activated T Cell Based Immunotherapy and Intensity–Modulated Radiotherapy" Cancers 3, no. 2: 2223-2242.
https://doi.org/10.3390/cancers3022223
APA Style
Hasumi, K., Aoki, Y., Watanabe, R., Hankey, K. G., & Mann, D. L.
(2011). Therapeutic Response in Patients with Advanced Malignancies Treated with Combined Dendritic Cell–Activated T Cell Based Immunotherapy and Intensity–Modulated Radiotherapy. Cancers, 3(2), 2223-2242.
https://doi.org/10.3390/cancers3022223